Maravai LifeSciences Shares Up 3.8 percent Still a Buy?
MRVI Stock | USD 4.77 0.20 4.38% |
Under 55% of Maravai Lifesciences' traders are presently thinking to get in. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that some investors are interested at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
Maravai |
Maravai LifeSciences Holdings, Inc. s stock price traded up 3.8 percent during trading on Tuesday . The stock traded as high as 5.87 and last traded at 5.79. 306,175 shares changed hands during trading, a decline of 86 percent from the average session volume of 2,216,026 shares. The stock had previously closed at
Read at thelincolnianonline.com
Maravai Lifesciences Fundamental Analysis
We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Maravai Lifesciences is currently under evaluation in target price category among its peers.
Maravai Lifesciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.
Peers
Maravai Lifesciences Related Equities
LEGN | Legend Biotech | 6.15 | ||||
INSM | Insmed | 5.85 | ||||
AKRO | Akero Therapeutics | 4.71 | ||||
HRMY | Harmony Biosciences | 3.61 | ||||
RARE | Ultragenyx | 3.20 | ||||
AGIO | Agios Pharm | 2.50 | ||||
ASND | Ascendis Pharma | 2.29 | ||||
INCY | Incyte | 2.14 | ||||
KRYS | Krystal Biotech | 2.13 | ||||
HALO | Halozyme Therapeutics | 2.08 | ||||
DNLI | Denali Therapeutics | 1.20 | ||||
ALEC | Alector | 1.17 | ||||
ROIV | Roivant Sciences | 1.08 | ||||
ARGX | Argenx NV | 1.07 | ||||
PTGX | Protagonist Therapeutics | 0.77 | ||||
APLS | Apellis Pharmaceuticals | 0.63 | ||||
FOLD | Amicus Therapeutics | 0.53 | ||||
ABUS | Arbutus Biopharma | 0.31 | ||||
CYTK | Cytokinetics | 0.17 | ||||
IMVT | Immunovant | 1.13 | ||||
EWTX | Edgewise Therapeutics | 1.72 | ||||
ARQT | Arcutis Biotherapeutics | 7.78 |
Complementary Tools for Maravai Stock analysis
When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |